Medline and Jiangsu Shenli Medical Production are at the center of the FDA’s probe of plastic syringes made in China.
Once a COVID-testing darling, Cue will close after raising hundreds of millions of dollars and striking high-profile partnerships with Google and the NBA during the pandemic.
May 22, 2024, ̶ Jade Global, a leading Silicon Valley-based Enterprise Technology services partner, is now HIPAA (Health ...
CEO Geoff Martha told investors there has already been “strong adoption” of PFA devices and the category will be a big part of Medtronic's revenue growth in fiscal year 2025.
The Biozorb devices are staying on the market, but Hologic has asked people to report adverse events such as pain.
By testing artificial intelligence and machine learning models, the agency hopes to come up with best practices for Parkinson’s measures from wearables and smartphones.
Feedback from the Heart Rhythm Society meeting suggests 50% to 70% of physicians could adopt the procedure “right out of the gate,” said Truist analyst Richard Newitter.
Burke Barrett will take over the role effectively immediately, while former CEO Kevin Danahy will become the chief commercial officer.
Agency scientists highlighted the risk in materials posted ahead of a Thursday advisory panel meeting for the Guardant Health blood test.
CEO Mattias Perjos said the action will have “some negative financial impact,” but the total effect will depend on customers' response.
The European Medicines Agency answered six new questions to clarify topics such as how companies can get advice on borderline products.
Cybersecurity group Nozomi Networks Labs identified 11 vulnerabilities across several systems and software in an investigation of imaging machines.